Pediatric Cancer Clinical Trials in San Francisco, California

6 studies are recruiting for pediatric cancer in San Francisco, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

    Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy. However, less than a quarter of patients with lung metastases will achieve…

    Stage
    Phase 2
    Ages
    2 to 25
    Site
    The Unviersity of California, San Francisco (UCSF), San Francisco, California
    Locations
    5 in total
    Run by
    Children's Hospital of Philadelphia
  2. Multisite Implementation of COMPRENDO

    COMPRENDO (ChildhOod Malignancy Peer Research NavigatiOn) is a multi-site randomized clinical trial (RCT) that uses a Hybrid Type 1 design, to test the effects of a clinical intervention on patient-level outcomes, while exploring multilevel implementation factors that can inform real-world setting …

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of California San Francisco Benioff Children's Hospitals, San Francisco, California
    Locations
    4 in total
    Run by
    University of California, San Diego
  3. Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma

    This study aims to evaluate the efficacy of Laser Interstitial Thermal Therapy (LITT) in treating recurrent or progressive, low-grade gliomas (LGG) in pediatric, adolescent and young adult patients.

    Stage
    Not phased
    Ages
    2 to 25
    Site
    University of California, San Francisco, San Francisco, California
    Run by
    University of California, San Francisco
  4. PediRISE Feasibility

    The goal of this research study is to learn whether investigators can successfully give the PediRISE program to families-in other words, whether most families are interested in participating in a study about the PediRISE program, including a 50-50 chance of receiving standard usual care, and a 50-5…

    Stage
    Not phased
    Ages
    Up to 17
    Site
    University of California San Francisco, San Francisco, California
    Locations
    4 in total
    Run by
    Dana-Farber Cancer Institute
  5. Targeted Therapy to Increase RAI Uptake in Metastatic DTC

    Papillary thyroid cancer (PTC) is a common type of differentiated thyroid cancer (DTC) in children and represents the second most common cancer in adolescent females. Recently targeted drugs that block many of the genetic drivers of DTC have become available. While Investigators know that these dru…

    Stage
    Not phased
    Ages
    0 and older
    Site
    University of California San Francisco, San Francisco, California
    Locations
    9 in total
    Run by
    Children's Hospital of Philadelphia
  6. Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

    Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy. However, less than a quarter of patients with lung metastases will achieve…

    Stage
    Phase 2
    Ages
    2 to 99
    Site
    University of California, San Francisco, San Francisco, California
    Locations
    5 in total
    Run by
    Children's Hospital of Philadelphia

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.